Intelligence · Clinical pipeline
Oncology · Phase I
Oncology programs at Phase I — ClinicalTrials.gov pipeline intelligence.
Quick answer
Oncology Phase I programs: NovaPharmaNews indexes 1,319 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 70 programs
- First People's Hospital 62 programs
- Takeda 49 programs
- United Therapeutics Europe 41 programs
- BEONE MEDICINES AUS 40 programs
- Regeneron UK 34 programs
- Anaxis Pharma 31 programs
- Chongqing Precision Biotech 27 programs
- Janssen-Cilag International N.V 27 programs
- Novartis India 27 programs
- Boehringer Ingelheim 24 programs
- BRIGHT MINDS BIOSCIENCES 23 programs
Pipeline programs
-
pCAR-19B cells
Chongqing Precision Biotech Co., Ltd
Acute Lymphoblastic Leukemia, in Relapse
1 trial -
pTVG-HP with rhGM-CSF
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
palifosfamide-tris
Alaunos Therapeutics
Advanced Solid Tumors
1 trial -
pd-1 and DC-NK cells
The First People's Hospital of Lianyungang
Solid Tumor
1 trial -
pd-1 and dc-cik cells
The First People's Hospital of Lianyungang
Solid Tumor
1 trial -
prophylactic 4SCAR19 cells
The First People's Hospital of Lianyungang
B Acute Lymphoblastic Leukemia
1 trial -
rSIFN-co
Sichuan Provincial People's Hospital
Carcinoma, Non-Small-Cell Lung
1 trial -
selinexor
Karyopharm Therapeutics Inc
Recurrent Melanoma
1 trial -
selinexor
Karyopharm Therapeutics Inc
B-cell Lymphoma
1 trial -
sphingosine kinase-2 inhibitor ABC294640
Apogee Therapeutics
Pancreatic Cancer
1 trial -
standard chemotherapy medicine combined with Chinese herbs
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
standard dose capecitabine
Karyopharm Therapeutics Inc
Rectal Neoplasms
1 trial -
uCD7 CART
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Myeloid Leukemia (AML)
1 trial -
universal CLL1 CAR-T cells
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
veliparib
BRIGHT MINDS BIOSCIENCES INC.
Small Cell Lung Cancer SCLC
1 trial -
zanzalintinib
Arcus Biosciences
Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
1 trial -
ziftomenib
Kura Oncology
Gastrointestinal Stromal Tumor (GIST)
1 trial -
zimberelimab
Arcus Biosciences
Advanced Solid Tumors
1 trial -
ziv-aflibercept
Regeneron UK Limited
Lymphoma
2 trials -
ziv-aflibercept
Regeneron UK Limited
Cancer
2 trials -
α-lactalbumin vaccine
Anixa Biosciences Inc
Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer
1 trial -
γδT Cell infusion agent
The First People's Hospital of Lianyungang
Leukemia, B-cell
1 trial -
MEN2501-01
Stemline Therapeutics B.V.
Platinum-Resistant ovarian cancer
1 trial
Frequently asked questions
How many oncology Phase I programs exist?
1,319 programs match both the therapeutic area and stage filters in our published index.